Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African-Americans

INTRODUCTION: The detection of mutations in the epidermal growth factor receptor (EGFR) gene, which predict sensitivity to treatment with EGFR tyrosine kinase inhibitors (TKIs), represents a major advance in the treatment of lung adenocarcinoma. KRAS mutations confer resistance to EGFR -TKIs. The pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Reinersman, J. Matthew, Johnson, Melissa L., Riely, Gregory J., Chitale, Dhananjay A., Nicastri, Anthony D., Soff, Gerald A., Schwartz, Ann G., Sima, Camelia S., Ayalew, Getinet, Lau, Christopher, Zakowski, Maureen F., Rusch, Valerie W., Ladanyi, Marc, Kris, Mark G.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3337520/
https://ncbi.nlm.nih.gov/pubmed/21107288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181fb4fe2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars